![]() One such technological advancement is Medtronic PLC's development of implantable tibial neuromodulation (TNM) device designed to relieve symptoms of Urinary Incontinence. Overactive bladder affects approximately 33 million people, representing symptoms of urgency, frequency, and urge incontinence.įurthermore, at the global level, the United States is the largest market at the global level, owing to the development of advanced devices and the government's simple regulatory initiatives. ![]() This dominance is due to the rising Urinary Incontinence prevalence and urological conditions among men and women in the region.Īccording to the Urology Care Foundation 2021, a quarter to a third of men and women in the United States suffer from Urinary Incontinence. But, North America is expected to dominate the global market. Geographically, the Urinary Incontinence Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. Urinary Incontinence Devices Market Insights ![]() To learn more about the condition, get a snapshot of Urinary Incontinence Treatment Landscape The incontinence treatment will depend on certain factors such as type of incontinence, physical activity, age, mental health, kegel exercises, and others and Shijiazhuang Biosphere Pty Ltd., of Hebei Province, China, to manufacture and distribute its Pericoach device for Urinary Incontinence in China, Macau, Hong Kong, and Taiwan. signed a joint venture agreement with Hebei Nacol Bio-Technology Co. In April 2021, in Australia, Analytica Ltd. Braun Melsungen AG, Flexicare (Group) Limited, InControl Medical, and others.Īs per DelveInsight estimates, the Global Urinary Incontinence Devices Market was valued at USD 2.8 billion in 2020 and is expected to grow at a CAGR of 6.32% from 2021 to 2026, reaching USD 4.03 billion by 2026.Īccording to findings from the feasibility phase of the SANS-UUI study, in September 2021 at the American Urological Association Annual Meeting, a novel, ultra-miniaturized sacral nerve modulation (SNM) system was shown to be both efficacious and safe in treating patients with UUI. Ltd., Teleflex Incorporated, Hollister Incorporated, ConvaTec Group PLC, Caldera Medical Inc., Prosurg, Inc., Laborie, Inc., Becton, Dickinson and Company, ZSI Surgical Implants, Atlantic Therapeutics, B. Bard Inc., Coloplast Corporation, Boston Scientific Corporation, Ethicon US, LLC, Medtronic PLC, A.M.I. Key players working proactively in the Urinary Incontinence Devices market include NeoTract, Inc., Cook Medical Inc., C.R. ![]() Some of the Key Highlights from the Urinary Incontinence Devices Market ReportĪccording to DelveInsight analysis, North America is expected to dominate the overall Urinary Incontinence Devices Market during the forecasted period. 15, 2022 (GLOBE NEWSWIRE) - Global Urinary Incontinence Devices Market is Expected to Grow at a CAGR of 6.32% During the Forecast Period (2021-26) | DelveInsightĭelveInsight's Urinary Incontinence Devices Market Insights and Forecast report provides the current and forecast Urinary Incontinence Devices market, forthcoming developments in the devices, individual market shares, challenges, drivers, barriers, market trends, and key companies in the Urinary Incontinence Devices market. As per DelveInsight analysis, a growing prevalence of Urinary Incontinence cases, the development of novel devices, an aging population prone to urological conditions such as urinary tract infections, pelvic floor weakness, and conditions such as pregnancy, diabetes, menopause, and Parkinson's disease are among the factors driving the Urinary Incontinence Devices market growth.
0 Comments
Leave a Reply. |